Clinical Trial Update: Lapatinib and Tamoxifen in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous Tamoxifen [Phase 2]

View source ↗

Summary

A Phase 2 study evaluated the combination of lapatinib and tamoxifen in patients with locally advanced or metastatic breast cancer that progressed on prior tamo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Estrogen Receptor-positive Breast Cancer
• Male Breast Cancer
• Stage Iiib Breast Cancer
• Stage Iiic Breast Cancer

Drugs mentioned

• Nolvadex (tamoxifen)
• Tykerb (lapatinib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Estrogen Receptor Positive, Male Breast Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2014-12-03